Browsing Tag

DoubleRainbow Biosciences

Landkind reaches significant regulatory milestone, achieving GRAS status for LK-01™ Pure Salidroside

Jason Junior Dec 19, 2022

LEXINGTON, MASS., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Landkind, a subsidiary of DoubleRainbow Biosciences leveraging advances in synthetic biology to deliver precision-engineered supplements to advance human health, today announced it has…

Health

Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic…

Jason Junior Nov 28, 2022

Lexington, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health, today announced the world’s first…

Health

DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound…

Jason Junior Aug 22, 2022

Lexington, MA, Aug. 22, 2022 (GLOBE NEWSWIRE) -- DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health, announced today a new research collaboration…